Clinical bottom line
Pulmonary Langerhans cell histiocytosis (PLCH) is a rare interstitial lung disease characterized by cystic and nodular lung lesions that can complicate anesthetic management due to risks of spontaneous pneumothorax, impaired gas exchange, and pulmonary hypertension. Current evidence on anesthetic outcomes in PLCH patients undergoing surgery is limited and largely derived from case reports and expert consensus. Careful preoperative assessment, avoidance of high airway pressures, and vigilant intraoperative monitoring are prudent strategies to mitigate perioperative respiratory complications. This evidence digest summarizes the pathophysiology relevant to anesthesia, highlights perioperative risks, and outlines considerations to optimize outcomes in this vulnerable population (Silverstone et al., 2022; Bourke et al., 2010).
What the evidence shows
PLCH predominantly affects young to middle-aged adults, often smokers, and manifests with progressive cystic lung destruction and granulomatous inflammation involving Langerhans cells (Macori et al., 2018). Radiologically, it is characterized by a combination of nodules and irregular cysts predominantly in the upper and mid lung zones (Nicoletti et al., 2019). The cystic changes predispose patients to spontaneous pneumothorax, which is a common clinical presentation and a significant perioperative risk (Silverstone et al., 2021).
From an anesthetic perspective, the structural lung abnormalities in PLCH increase the risk of barotrauma during positive pressure ventilation. High airway pressures can rupture fragile cyst walls, precipitating pneumothorax or air leak syndromes (Bourke et al., 2010). Additionally, PLCH may be associated with pulmonary hypertension secondary to vascular involvement, which complicates intraoperative hemodynamic management and increases perioperative morbidity (Silverstone et al., 2022).
Preoperative pulmonary function tests often reveal a mixed restrictive and obstructive pattern with reduced diffusion capacity, indicating impaired gas exchange (Macori et al., 2018). These abnormalities correlate with increased risk of hypoxemia during anesthesia. There is no high-quality prospective data on anesthetic outcomes in PLCH; however, case series and expert reviews emphasize the importance of minimizing airway pressures, using lung-protective ventilation strategies, and avoiding nitrous oxide due to risk of expanding cystic spaces (Silverstone et al., 2021; Bourke et al., 2010).
Postoperative respiratory complications, including prolonged oxygen requirement and pneumothorax, have been reported, underscoring the need for close monitoring in the immediate postoperative period (Nicoletti et al., 2019). Regional anesthesia techniques may be preferable when feasible to reduce pulmonary risks, but their applicability depends on the surgical procedure and patient factors.
Caveats and uncertainty
The rarity of PLCH and the absence of randomized controlled trials or large observational cohorts limit the strength of evidence guiding anesthetic management. Most available data are from case reports, small series, and expert opinion, which may be subject to publication bias and lack generalizability. The heterogeneity in disease severity and comorbidities further complicates risk stratification.
There is also limited information on the impact of different anesthetic agents and techniques on pulmonary outcomes in PLCH. The role of preoperative optimization, including smoking cessation and treatment of pulmonary hypertension, lacks robust evidence specific to this population. Moreover, the natural history of PLCH is variable, with some patients experiencing spontaneous remission, making perioperative risk assessment challenging.
Given these uncertainties, anesthesiologists must individualize care plans, integrating multidisciplinary input from pulmonologists and thoracic surgeons experienced in PLCH management.
How this may change practice
Awareness of PLCH as a distinct clinical entity with unique anesthetic challenges can improve perioperative risk assessment and planning. Incorporating detailed preoperative imaging review and pulmonary function testing helps identify patients at higher risk for complications such as pneumothorax and hypoxemia.
Anesthetic strategies should prioritize lung protection: using low tidal volumes, limiting peak airway pressures, and avoiding nitrous oxide. Consideration of regional anesthesia or sedation techniques may reduce pulmonary stress when appropriate. Vigilant intraoperative monitoring for signs of barotrauma and hemodynamic instability is essential, especially in patients with pulmonary hypertension.
Postoperative care should include early chest imaging if respiratory symptoms arise and readiness to manage pneumothorax promptly. Multidisciplinary coordination can facilitate optimization of pulmonary status preoperatively and enhance postoperative recovery.
Overall, this evidence digest highlights the need for cautious, tailored anesthetic management in PLCH patients and identifies gaps warranting further research to establish evidence-based guidelines.